Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher T Veldkamp

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Protein Expression and Purification|October 31, 2006
On-column refolding of recombinant chemokines for NMR studies and biological assaysChristopher T Veldkamp, Francis C Peterson, Paulette L Hayes, et al.
Science Signaling|September 19, 2008
Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12Christopher T Veldkamp, Christoph Seibert, Francis C Peterson, et al.
Protein Science : a Publication of the Protein Society|June 25, 2009
Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12Christopher T Veldkamp, Joshua J Ziarek, Jidong Su, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2011
Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathwaysLuke J Drury, Joshua J Ziarek, Stéphanie Gravel, et al.
Frontiers in Immunology|October 2, 2019
Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7Astrid S Jørgensen, Olav Larsen, Edith Uetz-von Allmen, et al.
Biochemistry|January 7, 2012
Solution structure of CCL21 and identification of a putative CCR7 binding siteMelissa Love, Jamie L Sandberg, Joshua J Ziarek, et al.
The Journal of Biological Chemistry|November 14, 2012
Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminusJoshua J Ziarek, Christopher T Veldkamp, Fuming Zhang, et al.
Biochemistry and Biophysics Reports|August 9, 2023
NMR indicates the N-termini of PSGL1 and CCR7 bind competitively to the chemokine CCL21Robin N Witt, Kaileigh S Nickel, John R Binns, et al.
Proteins|October 10, 2014
The solution structure of the forkhead box-O DNA binding domain of Brugia malayi DAF-16aSarah K Casper, Scott J Schoeller, Danielle M Zgoba, et al.
Biochemical and Biophysical Research Communications|June 25, 2016
Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin bindingAustin J Barmore, Sally M Castex, Brittany A Gouletas, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Protein Expression and Purification|October 31, 2006
On-column refolding of recombinant chemokines for NMR studies and biological assaysChristopher T Veldkamp, Francis C Peterson, Paulette L Hayes, et al.
Science Signaling|September 19, 2008
Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12Christopher T Veldkamp, Christoph Seibert, Francis C Peterson, et al.
Protein Science : a Publication of the Protein Society|June 25, 2009
Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12Christopher T Veldkamp, Joshua J Ziarek, Jidong Su, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2011
Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathwaysLuke J Drury, Joshua J Ziarek, Stéphanie Gravel, et al.
Frontiers in Immunology|October 2, 2019
Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7Astrid S Jørgensen, Olav Larsen, Edith Uetz-von Allmen, et al.
Biochemistry|January 7, 2012
Solution structure of CCL21 and identification of a putative CCR7 binding siteMelissa Love, Jamie L Sandberg, Joshua J Ziarek, et al.
The Journal of Biological Chemistry|November 14, 2012
Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminusJoshua J Ziarek, Christopher T Veldkamp, Fuming Zhang, et al.
Biochemistry and Biophysics Reports|August 9, 2023
NMR indicates the N-termini of PSGL1 and CCR7 bind competitively to the chemokine CCL21Robin N Witt, Kaileigh S Nickel, John R Binns, et al.
Proteins|October 10, 2014
The solution structure of the forkhead box-O DNA binding domain of Brugia malayi DAF-16aSarah K Casper, Scott J Schoeller, Danielle M Zgoba, et al.
Biochemical and Biophysical Research Communications|June 25, 2016
Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin bindingAustin J Barmore, Sally M Castex, Brittany A Gouletas, et al.
Pageof 4